-+ 0.00%
-+ 0.00%
-+ 0.00%

TELA Bio secures lender consent to waive minimum revenue covenant tests for Q3, Q4 2026

PUBT·09/29/2026 20:06:14
Listen to the news
TELA Bio secures lender consent to waive minimum revenue covenant tests for Q3, Q4 2026
  • TELA Bio entered a limited consent with Perceptive Credit Holdings V, as agent, plus required lenders under its November 2025 credit agreement.
  • The waiver suspends testing of the minimum revenue covenant for the quarters ending around Sept. 30, 2026, and Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-111920), on September 29, 2026, and is solely responsible for the information contained therein.